Bifidobacterium longum infantis M-63 and Modulated Multiple Sclerosis-Related Dysbiosis

• Dysbiosis and Therapeutic Modulation of the Gut Microbiota in Multiple Sclerosis: A Narrative Review.

  • 2025-12
  • Review
  • Health science reports 8(12)
  • • Mojtaba Memariani
    • Hamed Memariani

  • PubMed: 41341415
  • DOI: 10.1002/hsr2.71564

  3 Insights on

  • Modulated Multiple Sclerosis-Related Dysbiosis

  • Low evidence

  Altering the gut microbiota in patients with MS may serve as a potentially effective treatment strategy.

  Effect

  Beneficial

  Effect size

  Small